Ooki A, Morita S, Tsuji A, Iwamoto S, et al. Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial. BMC Cancer 2022;22:711.
PMID: 35765021